RadNet, Inc. (NASDAQ:RDNT) VP Mark Stolper sold 10,000 shares of the company’s stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $10.19, for a total transaction of $101,900.00. Following the completion of the transaction, the vice president now owns 145,319 shares in the company, valued at $1,480,800.61. The transaction was disclosed in a filing with the SEC, which is available at this link.

RadNet, Inc. (RDNT) traded up 0.97% on Thursday, reaching $10.45. 439,206 shares of the company’s stock were exchanged. RadNet, Inc. has a 1-year low of $5.25 and a 1-year high of $10.77. The firm’s 50 day moving average is $8.06 and its 200 day moving average is $6.89. The stock has a market capitalization of $493.93 million, a P/E ratio of 55.00 and a beta of 1.01.

RadNet (NASDAQ:RDNT) last announced its quarterly earnings data on Tuesday, August 8th. The medical research company reported $0.11 EPS for the quarter, topping the Zacks’ consensus estimate of $0.04 by $0.07. RadNet had a return on equity of 19.98% and a net margin of 1.04%. The firm had revenue of $230 million during the quarter, compared to analyst estimates of $230.32 million. During the same period last year, the company posted $0.09 EPS. The business’s quarterly revenue was up 5.2% compared to the same quarter last year. Analysts expect that RadNet, Inc. will post $0.29 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was illegally copied and reposted in violation of United States & international copyright and trademark law. The legal version of this report can be read at https://www.watchlistnews.com/radnet-inc-rdnt-vp-mark-stolper-sells-10000-shares/1534683.html.

RDNT has been the topic of a number of recent research reports. Jefferies Group LLC upgraded shares of RadNet from a “hold” rating to a “buy” rating and upped their target price for the company from $7.00 to $12.00 in a report on Tuesday, August 22nd. Zacks Investment Research upgraded shares of RadNet from a “sell” rating to a “hold” rating in a report on Wednesday, May 17th. BidaskClub upgraded shares of RadNet from a “buy” rating to a “strong-buy” rating in a report on Thursday, August 24th. Finally, TheStreet upgraded shares of RadNet from a “c” rating to a “b-” rating in a report on Thursday, August 24th. Two research analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $9.42.

Several large investors have recently made changes to their positions in RDNT. Airain ltd purchased a new stake in shares of RadNet during the second quarter valued at about $100,000. Campbell & CO Investment Adviser LLC purchased a new stake in shares of RadNet during the second quarter valued at about $102,000. National Planning Corp raised its stake in shares of RadNet by 9.8% in the second quarter. National Planning Corp now owns 16,796 shares of the medical research company’s stock valued at $132,000 after buying an additional 1,500 shares in the last quarter. Prudential Financial Inc. raised its stake in shares of RadNet by 29.2% in the first quarter. Prudential Financial Inc. now owns 17,710 shares of the medical research company’s stock valued at $104,000 after buying an additional 4,000 shares in the last quarter. Finally, Royce & Associates LP purchased a new stake in shares of RadNet during the first quarter valued at about $118,000. Institutional investors and hedge funds own 48.81% of the company’s stock.

RadNet Company Profile

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Insider Buying and Selling by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.